MD MEDNAX Inc.

MEDNAX’s American Anesthesiology to Exhibit at ASA’s PRACTICE MANAGEMENT 2018 Jan. 26-27

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is exhibiting as an American Society of Anesthesiologists (ASA) Conference Supporter at PRACTICE MANAGEMENT™ 2018: Navigating for Success from January 26-27 at the Hyatt Regency New Orleans. MEDNAX/American Anesthesiology physicians and leadership will be on-site at Booth #701.

PRACTICE MANAGEMENT 2018 brings together subject-matter experts and leaders in anesthesia to share knowledge and critical skills needed to stay at the forefront of anesthesia practice management. Attendees will discover how to deliver value through physician and practice performance, and engage with a variety of world-renowned specialty leaders.

“The ASA Practice Management conference provides a unique opportunity for MEDNAX to network with and learn from other industry leaders, and discuss the challenges we face as the health care environment continues to undergo revolutionary changes,” said Michael Murphy, M.D., Chief Medical Officer for Anesthesiology and Adult Critical Care at MEDNAX. “We value this time to connect with national anesthesia leaders.”

For more information or to schedule an on-site meeting, please contact [email protected].

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner based in Sunrise, Fla. comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of approximately 4,075 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.

EN
23/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 23,000 shares at 22.410USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch